ABSA International
ABSA International

Resources with keywords: treatment



Monkeypox: Updates on Testing, Vaccination & Treatment
CDC/Infectious Diseases Society of America (IDSA)
23 July 2022

Webinar

Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 (Website, Regulatory)
CDC/Health Alert Network (HAN)
25 April 2022
Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant (Website, Regulatory)
FDA
11 February 2022
Do I Still Need a Pulse Oximeter?
New York Times (NYT)
7 October 2021

New research from South Africa shows that using a pulse oximeter to check oxygen levels after a Covid diagnosis really does save lives.

Using Therapeutics to Prevent and Treat COVID-19
CDC / Health Alert Network

Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study (NEW 10/15, Website)
Merck
1 October 2021
keywords: covid-19, treatment
Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments (Website, Regulatory)
FDA
ARCHIVED: Once-a-Day Pill to Treat Covid-19 Is Tested (Document, News)
Wall Street Journal (WSJ)
26 July 2021
Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021 (NEW 8/3, Website, Publication)
CDC/MMWR
30 July 2021

Lee JT, Althomsons SP, Wu H, et al.

ARCHIVED: Antibody Drug Cuts Risk of Death for Sickest Patients (Document, News)
Wall Street Journal
16 June 2021

Trial results for a new Regeneron treatment have buoyed hopes that doctors could soon have a new way to tackle severe hospital cases.

Go to Top